Evidence map›Paper›PMID 40309307›Full record

ArticleJournal of inflammation research2025

The Association of Systemic Immune Inflammation Index (SII) and Platelet-to-Lymphocyte Ratio (PLR) on Coagulopathy and Prognosis in Patients with Traumatic Brain Injury.

Jiali Chen, Jiahui Fu, Jiazhuo Liu, Yin Lu, Dong Han, Jiaxuan Zeng, Zhimin Zou, Qin Li, Kun Zhang, Xiucai Wei and 2 more

Abstract read
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jiali ChenDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Jiahui FuDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Jiazhuo LiuDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Yin LuDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Dong HanDepartment of Quality Control and Evaluation, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.ORCID 0000-0002-7426-184X
Jiaxuan ZengDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Zhimin ZouDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Qin LiDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Kun ZhangDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Xiucai WeiDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
Li LiDepartment of Emergency Medicine, General Hospital of Southern Theatre Command of PLA, Guangzhou, Guangdong, People's Republic of China.ORCID 0000-0001-5889-8667
Zhengtao GuDepartment of Treatment Center For Traumatic Injuries, The Third Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.ORCID 0000-0001-8566-6634

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: We aimed to investigate the associations between inflammatory immune indicators, specifically systemic immune inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and the coagulopathy and prognosis of traumatic brain injury (TBI) patients in ICU. Methods: One hundred sixty-one TBI patients were grouped into four groups. The outcomes included TBI-related coagulopathy and prognosis at six months after discharge. The association between SII, PLR and coagulopathy, and prognosis in TBI patients was elucidated by applying trend analysis, sensibility analysis, spearman correlation, restricted cubic splines and so on. Results: Sixty-four (39.75%) of 161 TBI patients were diagnosed with coagulopathy. In the unadjusted model, TBI patients in the lowest quarter of SII (≤966.60) and PLR levels (≤97.99) had a higher risk of coagulopathy than those in the highest quarter of SII (≥3096.16) [OR 0.169 (95% CI 0.052-0.547)] and PLR (≥255.39) [OR 0.098 (95% CI 0.028-0.340)]. After adjusting for covariates, the significant negative associations of results remained consistent in the sensitivity analyses. Restricted cubic splines revealed that an almost linear relationship between SII, PLR and coagulopathy risk and poor prognosis ( Conclusion: This study demonstrated that the SII and PLR had a significant correlation with coagulopathy risk and prognosis at 6 months after discharge. SII and PLR were predictive of coagulopathy and poor prognosis, specifically PLR value. It suggests that the SII and PLR might be promising biomarkers for predicting TBI-related coagulopathy and prognosis. Trial Registration: The study was registered in the ethics committee of the Third Affiliated Hospital of Southern Medical University (2024-ER-005).

Indexed as

coagulopathyinflammationPLRprognosisSIItraumatic brain injury

Identifiers

PMID40309307
PMCPMC12042205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.